Reply to: "Sorafenib or (90) Y loaded resin microsphere radioembolization for locally-advanced hepatocellular carcinoma, what should we trust?"

Liver Int. 2015 Jun;35(6):1780-1. doi: 10.1111/liv.12823. Epub 2015 Apr 5.

Authors

Annagiulia Gramenzi¹, Cinzia Pettinato², Alberta Cappelli³, Cristina Mosconi³, Rita Golfieri³, Franco Trevisani¹

Affiliations

¹ Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
² Radiology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.
³ Medical Physics Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.

PMID: 25778710
DOI: 10.1111/liv.12823

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Carcinoma, Hepatocellular / therapy*
Embolization, Therapeutic*
Female
Humans
Liver Neoplasms / therapy*
Male
Niacinamide / analogs & derivatives*
Phenylurea Compounds / therapeutic use*
Yttrium Radioisotopes / therapeutic use*

Substances

Antineoplastic Agents
Phenylurea Compounds
Yttrium Radioisotopes
Niacinamide